Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Non-tumor necrosis factor (TNF) drugs are more effective than anti-TNF drugs in some patients with rheumatoid arthritis, according to the results of a clinical trial that were published in the ... Read more
Mesoblast Limited’s mesenchymal precursor cell (MPC) product candidate MPC-300-IV is well tolerated and results in a dose-dependent improvement in clinical symptoms, physical function, and disease activity in patients with refractory rheumatoid ... Read more
Stimulating the vagus nerve with electrical signals significantly improves disease severity of rheumatoid arthritis (RA), according to a new study, “Vagus nerve stimulation inhibits cytokine production and attenuates disease severity ... Read more
DNA methylation, a biological mechanism that controls which genes will be expressed and which ones will be silenced in different cells, varies between the cells lining the inside of different ... Read more
Genetic profiling could be used to predict whether or not patients with rheumatoid arthritis (RA) will respond to treatment, according to two new studies. The results were presented at the ... Read more